Follicum AB
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Follicum AB - overview
Established
2004
Location
Lund, -, Sweden
Primary Industry
Biotechnology
About
Follicum AB is a biotechnology company focused on developing innovative treatments for hair loss, leveraging proprietary peptides to stimulate hair follicle activity and promote hair regeneration. Founded in 2004 and headquartered in Lund, Sweden, Follicum AB develops therapeutic solutions for hair loss. The company has engaged in three total funding deals, with the most recent occurring on August 29, 2018, when it raised DKK 1 million in a GRANT from the Novo Nordisk Foundation. To date, Follicum has raised a total of DKK 0.
50 mn. The company was founded without reference to a parent company or notable mergers. Follicum specializes in the development of treatments for hair loss, focusing on innovative peptides designed to stimulate hair follicle activity and enhance hair regeneration. These products target biological pathways relevant to conditions like androgenetic alopecia, serving both consumers dealing with hair loss and healthcare providers seeking effective treatments in dermatology and trichology.
The company’s solutions are distributed in various regions, including Europe and North America. Follicum generates revenue through direct-to-consumer sales and partnerships with healthcare providers and distributors. The transaction structure focuses on relationships with clinics and dermatologists, who recommend Follicum's peptide products to patients experiencing hair loss. The revenue comes from these signature products, which are offered via subscription plans or one-time purchases, facilitating consistent user engagement while ensuring steady revenue flow.
Specific pricing details are proprietary, reflecting Follicum's positioning in the hair care market. Follicum AB aims to expand its product line and enter new markets. The most recent funding round on August 29, 2018, involved DKK 1 million, part of a larger DKK 1. 40 million grant, which is intended to support further product development and market expansion initiatives.
Target markets for growth include increasing presence in North America and enhancing product offerings within Europe.
Current Investors
Heartcore Capital, Novo Nordisk Foundation
Primary Industry
Biotechnology
Sub Industries
Biotechnology, Healthcare
Website
www.follicum.com
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Follicum AB - financials
| Fiscal Year Ended | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | - | - | - | - | - | - | - | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| EBITDA (USD) | (614,164) | (1,868,557) | (5,239,338) | (6,227,763) | (19,087,924) | (20,560,779) | (17,449,503) | - | - | - |
| Operating Income (USD) | (614,164) | (1,868,557) | (5,239,338) | (6,227,763) | (19,087,924) | (20,560,779) | (17,563,553) | - | - | - |
| Operating Margin | - | - | - | - | - | - | - | - | - | - |
| % EBITDA Margin | - | - | - | - | - | - | - | - | - | - |
| NET Income (USD) | (607,575) | (1,848,044) | (5,185,603) | (6,183,181) | (19,021,471) | (20,536,742) | (17,519,556) | - | - | - |
| % Net Margin | - | - | - | - | - | - | - | - | - | - |
Follicum AB - employee data

Follicum AB - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Board Member | BM | ||||||
| Member of the Board | BM | ||||||
| Chairman of the board/board member from Oct. 1 2015 | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.